Member access

4-Traders Homepage  >  Shares  >  Italian Stock Exchange  >  DiaSorin SpA    DIA   IT0003492391

DIASORIN SPA (DIA)

15
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Italian Stock Exchange
04/21/2015 04/22/2015 04/23/2015 04/24/2015 04/27/2015 Date
41.13(c) 41.26(c) 40.92(c) 41.09(c) 41.18 Last
51 380 39 543 47 683 36 137 103 981 Volume
+1.18% +0.32% -0.82% +0.42% +0.22% Change
More quotes
Financials (€)
Sales 2015 483 M
EBIT 2015 147 M
Net income 2015 94,6 M
Finance 2015 81,8 M
Yield 2015 1,55%
Sales 2016 511 M
EBIT 2016 158 M
Net income 2016 102 M
Finance 2016 105 M
Yield 2016 1,62%
PER 2015 23,89
PER 2016 22,13
EV / Sales 2015 4,59x
EV / Sales 2016 4,29x
Capitalization 2 299 M
More Financials
Company
DiaSorin SpA engages in the development, production, and marketing reagent kits for in vitro diagnostics.It operates through the Immunodiagnostics and Molecular Diagnostics segments.The Immunodiagnostics segment manufactures and distributes immunoreagent kits based on chemiluminescence,... 
More about the company
Surperformance© ratings of DiaSorin SpA
Trading Rating : Investor Rating :
More Ratings
Latest news on DIASORIN SPA
04/14 DIASORIN : Launches 2 New Tests For The Quantitative Determination Of Bordetella..
03/23 DIASORIN : In Aid Of Haiti's Children In Partnership With The Francesca Rava Fou..
01/13 DIASORIN : Sources Sought Notice - 66-- 501-15-3-085-0038 Diasorin Analyzer, Rea..
2014DIASORIN SPA : quaterly earnings release
2014 DIASORIN : launches the stool test for Adenovirus on LIAISON
2014 DIASORIN : Announces New Webinar in Their Annual Vitamin D Series
2014 DIASORIN : The Board of Directors approves the results for H1'14
2014 DIASORIN : Confirms its eligibility for the pea-pme
More news
Sector news : Diagnostic & Testing Substances
04:07p MEDTRONIC : FDA moves to halt Medtronic's production of drug pump
03:34p MEDTRONIC : Announces Consent Decree with FDA for the Synchromed Drug Infusion S..
11:02a MEDTRONIC : Starts Clinical Study of Endurant Evo AAA Stent Graft System for End..
More sector news : Diagnostic & Testing Substances


Comments 
Advertisement
Chart DIASORIN SPA
Duration : Period :
DiaSorin SpA Technical Analysis Chart | DIA | IT0003492391 | 4-Traders
Full-screen chart
Technical analysis trends
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF